GSK-2636771
GSK-2636771 Uses, Dosage, Side Effects, Food Interaction and all others data.
GSK2636771 has been used in trials studying the treatment of CANCER, LYMPHOMA, Solid Neoplasm, Recurrent Solid Neoplasm, and Advanced Malignant Neoplasm, among others.
| Trade Name | GSK-2636771 |
| Generic | GSK-2636771 |
| Type | |
| Formula | C22H22F3N3O3 |
| Weight | Average: 433.431 Monoisotopic: 433.161326069 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here GSK-2636771
